Delve Health helps emerging biotechs run efficient, high-quality decentralized and hybrid studies — without needing massive teams or complex multi-vendor setups.
Book a Biotech DemoBiotechs need to move quickly, operate lean, and build evidence that stands up to regulatory scrutiny. Delve Health brings together eCOA, wearables, diaries, patient engagement, and concierge support into one platform purpose-built for smaller teams.
Launch eCOA + wearables in weeks — not months.
Validated digital biomarkers aligned with regulatory guidance.
Multilingual support ensures patients stay engaged and compliant.
Automated oversight + human support reduces operational load.
Early-phase and exploratory studies rely on accurate, continuous data. Delve provides a single, validated infrastructure for collecting both subjective and objective endpoints.
Early-phase studies struggle with variability. When a patient gets stuck, a device misbehaves, or a diary is missed — our concierge intervenes in real time to protect data quality.
Objective signals validated against gold-standard methods.
92% ePRO completion across a hard-to-reach population.
35% faster data readouts with real-time dashboarding.
One platform. Validated endpoints. Human retention. Everything a biotech needs to scale evidence.
Book a Biotech Demo